Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Dong-A Socio Holdings Co. Ltd.
DescriptionInterferon (IFN) beta
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase I
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat multiple sclerosis (MS)
Regulatory Designation
PartnerDong-A ST Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today